Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huoxiang Zhengqi Oral Liquid vs olanzapine-based quadruple regimen for prevention of cisplatin-induced CINV
ChiCTR2500104728Phase 2Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2025
- Countries
- 1
01
Overview
A Phase 2 trial of Huoxiang Zhengqi in chemotherapy-induced nausea and vomiting (CINV), sponsored by West China Hospital of Sichuan University. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
Huoxiang Zhengqi
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on ChiCTR2500104728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104728.